Free
![MedPresence](https://is1-ssl.mzstatic.com/image/thumb/Purple125/v4/f4/ce/e7/f4cee7b0-696a-acb1-6c20-1e62d2e1a91f/AppIcon-1x_U007emarketing-0-7-0-85-220.png/100x0w.png)
MedPresence
⭐️4.3 / 5
Rating
🙌11
Ratings
📼4 scs
Content
📦w/o updates
Updates frequency
- Versions
- Price History
- Description
- FAQ
All Versions of MedPresence
10.4
June 4, 2021
This release includes infrastructure upgrades and bug fixes
10.3.2
July 29, 2020
This release provides a Session Audit Report feature that allows DPOs to identify the participants that attended previous sessions. This release also extends Secure Invites and Annotations to nCare units
More10.3.1
May 26, 2020
Bug fixing
10.3
December 9, 2019
Bug fixes and support for EU region
10.2.1
March 8, 2019
Secure invites for guest practitioners added
10.2
December 20, 2018
Price History of MedPresence
Description of MedPresence
Olympus MedPresence® permits clinicians performing surgery to share views of the procedure room and imaging sources with colleagues outside the room using the Olympus MedPresence App on team members’ smartphones or tablets. MedPresence enables visual and audio collaboration between physicians through mobile device annotation, camera, microphone, and speaker features and audio-visual equipment inside the procedure room.
MedPresence: FAQ
Yes, MedPresence is compatible with iPad devices.
The MedPresence app was developed by Image Stream Medical Inc.
The app needs iOS 9.0 or later to function properly.
MedPresence has a consumer rating of 4.3 and receives plenty of positive reviews.
The Main Genre Of The Medpresence App Is Medical.
10.4 is the latest released MedPresence version.
MedPresence rolled out its latest update on July 3, 2024.
MedPresence originally came out on February 5, 2023.
Contains graphic violence, sexual content, or drug use, suitable for adults only.
MedPresence is available in .
No, MedPresence is not featured on Apple Arcade.
No, MedPresence does not include options for in-app purchases.
No, you cannot use MedPresence with Apple Vision Pro.